Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rhythm Pharmaceuticals Inc.

100.69
+1.281.29%
Post-market: 100.690.00000.00%16:10 EST
Volume:643.25K
Turnover:64.91M
Market Cap:6.72B
PE:-32.42
High:101.98
Open:99.85
Low:99.57
Close:99.41
52wk High:116.00
52wk Low:45.91
Shares:66.74M
Float Shares:53.42M
Volume Ratio:0.99
T/O Rate:1.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1057
EPS(LYR):-4.3376
ROE:-85.79%
ROA:-26.74%
PB:45.15
PE(LYR):-23.21

Loading ...

Pamela J. Cramer, Chief Human Resources Officer, Reports Disposal of Common Shares in Rhythm Pharmaceuticals Inc

Reuters
·
Jul 30

Rhythm Pharmaceuticals to Announce Second Quarter 2025 Financial Results

Reuters
·
Jul 23

BRIEF-Rhythm Pharmaceuticals Says Phase 2 Signal Trial Shows Bivamelagon Reduces BMI In Hypothalamic Obesity

Reuters
·
Jul 13

Rhythm Pharmaceuticals Unveils Promising Phase 3 Trial Results for Setmelanotide in Treating Acquired Hypothalamic Obesity at ENDO 2025

Reuters
·
Jul 13

CFO Hunter C. Smith Reports Disposal of Common Shares of Rhythm Pharmaceuticals Inc

Reuters
·
Jul 12

Rhythm Pharmaceuticals Raises $188.7 Million in Public Offering to Fund Clinical Development and Commercialization Efforts

Reuters
·
Jul 11

Rhythm Pharmaceuticals Is Maintained at Outperform by Oppenheimer

Dow Jones
·
Jul 11

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, AbbVie, McDonald's

Reuters
·
Jul 11

Morgan Stanley Raises Price Target on Rhythm Pharmaceuticals to $95 From $80, Keeps Overweight Rating

MT Newswires Live
·
Jul 10

BRIEF-Rhythm Pharmaceuticals Announces Pricing Of Upsized Public Offering Of Common Stock

Reuters
·
Jul 10

BUZZ-Rhythm Pharma unveils $150 mln equity offering after stock soars

Reuters
·
Jul 10

Rhythm Pharmaceuticals Announces $150 Million Public Offering of Common Stock

Reuters
·
Jul 10

US Equity Markets Higher, Nasdaq Reaches New Record High Following Nvidia Milestone

MT Newswires Live
·
Jul 10

Sector Update: Health Care Stocks Softer Wednesday Afternoon

MT Newswires Live
·
Jul 10

BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Warner Music Group, GeneDx

Reuters
·
Jul 10

Rhythm Pharmaceuticals Up Nearly 31%, on Track for Record High Close -- Data Talk

Dow Jones
·
Jul 10

Rhythm Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
Jul 10

Rhythm Pharma Shares Gain on Positive Results From Recent Trial of Obesity Treatment

Dow Jones
·
Jul 09

BUZZ-Rhythm rises as drug helps patients with rare form of obesity in small trial

Reuters
·
Jul 09

Rhythm Pharmaceuticals to Announce Topline Results from Phase 2 Trial of Oral MC4R Agonist Bivamelagon for Acquired Hypothalamic Obesity

Reuters
·
Jul 09